CoChat

Liraglutide Inhibits Endothelial-to-Mesenchymal Transition and Attenuates Neointima Formation after Endovascular Injury in Streptozotocin-Induced Diabetic Mice

Open access

The DOI matches its Crossref record; 60 of the 62 references it cites were found in a registry or an index.

Abstract

Hyperglycaemia causes endothelial dysfunction, which is the initial process in the development of diabetic vascular complications. Upon injury, endothelial cells undergo an endothelial-to-mesenchymal transition (EndMT), lose their specific marker, and gain mesenchymal phenotypes. This study investigated the effect of liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist, on EndMT inhibition and neointima formation in diabetic mice induced by streptozotocin. The diabetic mice with a wire-induced vascular injury in the right carotid artery were treated with or without liraglutide for four weeks. The degree of neointima formation and re-endothelialisation was evaluated by histological assessments. Endothelial fate tracing revealed that endothelium-derived cells contribute to neointima formation through EndMT in vivo. In the diabetic mouse model, liraglutide attenuated wire injury-induced neointima formation and accelerated re-endothelialisation. In vitro, a high glucose condition (30 mmol/L) triggered morphological changes and mesenchymal marker expression in human umbilical vein endothelial cells (HUVECs), which were attenuated by liraglutide or Activin receptor-like 5 (ALK5) inhibitor SB431542. The inhibition of AMP-activated protein kinase (AMPK) signaling by Compound C diminished the liraglutide-mediated inhibitory effect on EndMT. Collectively, liraglutide was found to attenuate neointima formation in diabetic mice partially through EndMT inhibition, extending the potential therapeutic role of liraglutide.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells8060589

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Liraglutide promotes endothelium recovery and reduces neointima formation in wire-injured carotid arteries of diabetic mice. Streptozotocin (STZ)-induced diabetic C57BL/6 mice were subjected to a wire-induced carotid artery injury with or without liraglutide treatment. (a) The percentage of the area of re-endothelisation was determined after the systemic injection of Evans blue at day one and day five (n = 3 per group). The stained blue area corresponds to the area with poor re-endothelialisation. The black arrowheads point at the area without blue staining area, which indicated re-endothelialised cells. Data are shown as mean ± SEM. * P < 0.05 analyzed by Student’s t-test. (b) The right common carotid arteries were collected on day 28 post-injury for haematoxylin and eosin (H and E) staining to evaluate the severity of neointima formation between groups. Data are shown as the mean ± SD (all groups, n = 10 per group), * P < 0.05 analyzed by Student’s t-test. IEL, internal elastic lamina; EEL, external elastic lamina; L, lumen; I, intima; M, media; A, adventitia.
Figure 1 Liraglutide promotes endothelium recovery and reduces neointima formation in wire-injured carotid arteries of diabetic mice. Streptozotocin (STZ)-induced diabetic C57BL/6 mice were subjected to a wire-induced carotid artery injury with or without liraglutide treatment. (a) The percentage of the area of re-endothelisation was determined after the systemic injection of Evans blue at day one and day five (n = 3 per group). The stained blue area corresponds to the area with poor re-endothelialisation. The black arrowheads point at the area without blue staining area, which indicated re-endothelialised cells. Data are shown as mean ± SEM. * P < 0.05 analyzed by Student’s t-test. (b) The right common carotid arteries were collected on day 28 post-injury for haematoxylin and eosin (H and E) staining to evaluate the severity of neointima formation between groups. Data are shown as the mean ± SD (all groups, n = 10 per group), * P < 0.05 analyzed by Student’s t-test. IEL, internal elastic lamina; EEL, external elastic lamina; L, lumen; I, intima; M, media; A, adventitia.CC BY · PubMed Central
Figure 2 Endothelia-derived cells contribute to neointima formation through EndMT. (a) Schematic representation of the induction of endothelial-specific GFP labelling after tamoxifen injection in TekCreERT2/DRG mice. (b) Representative images of immunofluorescence staining for the protein expression of GFP (green) and α-SMA (red) in the common carotid artery. Nuclei were counterstained with 4′,6-diamidino-2-phenylindole·2HCl (DAPI) (blue). The enlarged field (yellow square) represents the GFP expression in the endothelial layer of the carotid artery. (c) STZ-induced diabetic TekCreERT2/DRG mice were subjected to a wire-induced injury or a wire injury plus liraglutide treatment (n = 4 in each group). The common carotid arteries were collected on day 28. Representative images show the immunofluorescence staining for GFP (green), α-SMA (red), and nuclei (blue) in wire-injured common carotid arteries. The enlarged field (yellow square) represents the co-localization of GFP expression in α-SMA-positive cells (white arrowheads) in the neointima. (d) Quantification of the number of GFP+SMA+ cells in the neointima area between groups. (e) Quantification of the neointima to media ratio between groups. * P < 0.05, analyzed by Student’s t-test.
Figure 2 Endothelia-derived cells contribute to neointima formation through EndMT. (a) Schematic representation of the induction of endothelial-specific GFP labelling after tamoxifen injection in TekCreERT2/DRG mice. (b) Representative images of immunofluorescence staining for the protein expression of GFP (green) and α-SMA (red) in the common carotid artery. Nuclei were counterstained with 4′,6-diamidino-2-phenylindole·2HCl (DAPI) (blue). The enlarged field (yellow square) represents the GFP expression in the endothelial layer of the carotid artery. (c) STZ-induced diabetic TekCreERT2/DRG mice were subjected to a wire-induced injury or a wire injury plus liraglutide treatment (n = 4 in each group). The common carotid arteries were collected on day 28. Representative images show the immunofluorescence staining for GFP (green), α-SMA (red), and nuclei (blue) in wire-injured common carotid arteries. The enlarged field (yellow square) represents the co-localization of GFP expression in α-SMA-positive cells (white arrowheads) in the neointima. (d) Quantification of the number of GFP+SMA+ cells in the neointima area between groups. (e) Quantification of the neointima to media ratio between groups. * P < 0.05, analyzed by Student’s t-test.CC BY · PubMed Central
Figure 3 High glucose induces mesenchymal-like phenotypes in human umbilical venous endothelial cells (HUVECs). HUVECs were cultured in a control medium with a normal glucose level (NG, 5.5 mM of glucose), mannitol (M, 5.5 mM of glucose + 24.5 mM of mannitol), or high glucose (HG, 30 mM of glucose). (a) Representative bright-field images show the morphological changes in cells after 96 h of culture at different conditions. Scale bar represents 200 μm. The expression of VE-cadherin (green) and SM22α (red) in each group was analyzed using immunofluorescence staining. Nuclei were counterstained with DAPI (blue). HUVECs cultured in a HG medium showed a higher SM22α expression and a lower VE-cadherin expression compared to those in NG- or mannitol-treated groups. Scale bar represents 50 μm. (b) qRT-PCR analysis of the mRNA levels of CD31, SM22α, vimentin, and Snail in NG-, mannitol-, and HG-treated HUVECs. Data are shown as the mean ± SD from three independent experiments. * P < 0.05. The statistical significance was assessed by Kruskal–Wallis test.
Figure 3 High glucose induces mesenchymal-like phenotypes in human umbilical venous endothelial cells (HUVECs). HUVECs were cultured in a control medium with a normal glucose level (NG, 5.5 mM of glucose), mannitol (M, 5.5 mM of glucose + 24.5 mM of mannitol), or high glucose (HG, 30 mM of glucose). (a) Representative bright-field images show the morphological changes in cells after 96 h of culture at different conditions. Scale bar represents 200 μm. The expression of VE-cadherin (green) and SM22α (red) in each group was analyzed using immunofluorescence staining. Nuclei were counterstained with DAPI (blue). HUVECs cultured in a HG medium showed a higher SM22α expression and a lower VE-cadherin expression compared to those in NG- or mannitol-treated groups. Scale bar represents 50 μm. (b) qRT-PCR analysis of the mRNA levels of CD31, SM22α, vimentin, and Snail in NG-, mannitol-, and HG-treated HUVECs. Data are shown as the mean ± SD from three independent experiments. * P < 0.05. The statistical significance was assessed by Kruskal–Wallis test.CC BY · PubMed Central
Figure 4 High glucose promotes EndMT in HUVECs. (a) Representative images of the western blot analysis of p-Smad2 protein levels. Total Smad2/3 served as the loading control. The quantification of protein levels is presented as mean ± SD from three independent experiments. (b) Representative images of the western blot analysis of CD31, SM22α, vimentin, and Snail protein levels in HUVECs treated with different conditions. (c) Quantification of the relative fold increase is shown as the mean ± SD from three independent experiments. * P < 0.05. The statistical significance was assessed by Kruskal–Wallis test.
Figure 4 High glucose promotes EndMT in HUVECs. (a) Representative images of the western blot analysis of p-Smad2 protein levels. Total Smad2/3 served as the loading control. The quantification of protein levels is presented as mean ± SD from three independent experiments. (b) Representative images of the western blot analysis of CD31, SM22α, vimentin, and Snail protein levels in HUVECs treated with different conditions. (c) Quantification of the relative fold increase is shown as the mean ± SD from three independent experiments. * P < 0.05. The statistical significance was assessed by Kruskal–Wallis test.CC BY · PubMed Central
Figure 5 Liraglutide attenuates high glucose- and IL-1β-induced TGF-β signaling in HUVECs. HUVECs were cultured in the conditions indicated for 24 h. Cells were harvested for western blot analyses of the protein levels of (a) TGF-β and Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as an internal control, (b) p-Smad2 and total Smad2/3 as an internal control, and (c) p-AMPK and total AMPK as an internal control. Quantification of the relative fold increase is shown as the mean ± SD from three independent experiments. * P < 0.05 compared to saline control. # P < 0.05 compared to HG+IL-1β group. The statistical significance was assessed by Kruskal–Wallis test.
Figure 5 Liraglutide attenuates high glucose- and IL-1β-induced TGF-β signaling in HUVECs. HUVECs were cultured in the conditions indicated for 24 h. Cells were harvested for western blot analyses of the protein levels of (a) TGF-β and Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as an internal control, (b) p-Smad2 and total Smad2/3 as an internal control, and (c) p-AMPK and total AMPK as an internal control. Quantification of the relative fold increase is shown as the mean ± SD from three independent experiments. * P < 0.05 compared to saline control. # P < 0.05 compared to HG+IL-1β group. The statistical significance was assessed by Kruskal–Wallis test.CC BY · PubMed Central
Figure 6 Liraglutide inhibits EndMT in HUVECs via the AMPK pathway. HUVECs were cultured in the following four conditions for 72 h: (1) Saline; (2) HG (30 mM glucose) plus IL-1β; (3) HG plus IL-1β and Liraglutide; (4) Liraglutide and Compound C. Cell lysates were collected for western blot analyses. (a) Western blot analysis of the protein levels of p-AMPKα and p-Smad2. Total AMPKα and Smad2/3 were used as loading controls for p-AMPK and p-Smad2, respectively. (b) Western blot analysis of the protein levels of CD31, SM22α, vimentin, and Snail in HUVECs treated with different conditions. Β-actin was used as the loading control. (c) Quantification of the relative fold increase is shown as the mean ± SD from three independent experiments. * P < 0.05. The statistical significance was assessed by Kruskal–Wallis test.
Figure 6 Liraglutide inhibits EndMT in HUVECs via the AMPK pathway. HUVECs were cultured in the following four conditions for 72 h: (1) Saline; (2) HG (30 mM glucose) plus IL-1β; (3) HG plus IL-1β and Liraglutide; (4) Liraglutide and Compound C. Cell lysates were collected for western blot analyses. (a) Western blot analysis of the protein levels of p-AMPKα and p-Smad2. Total AMPKα and Smad2/3 were used as loading controls for p-AMPK and p-Smad2, respectively. (b) Western blot analysis of the protein levels of CD31, SM22α, vimentin, and Snail in HUVECs treated with different conditions. Β-actin was used as the loading control. (c) Quantification of the relative fold increase is shown as the mean ± SD from three independent experiments. * P < 0.05. The statistical significance was assessed by Kruskal–Wallis test.CC BY · PubMed Central
Figure 7 Liraglutide activates AMPK and enhances endothelial recovery in vivo. (a) STZ-induced diabetic C57BL/6 mice were subjected to a wire-induced carotid artery injury with or without liraglutide treatment. The expression of α-SMA (green) and p-AMPK (red) in the carotid arteries was analyzed by immunofluorescence staining. The endothelium was labelled by isolectin B4 (IB4, grey). Nuclei were stained with DAPI. (b) Number of p-AMPK+IB4+ endothelial cells per high-power field (HPF). (c) Percentage of endothelial coverage of the vascular lumen. Data are shown as mean ± SD, from three independent experiments. * P < 0.05. The statistical significance was assessed by Kruskal–Wallis test.
Figure 7 Liraglutide activates AMPK and enhances endothelial recovery in vivo. (a) STZ-induced diabetic C57BL/6 mice were subjected to a wire-induced carotid artery injury with or without liraglutide treatment. The expression of α-SMA (green) and p-AMPK (red) in the carotid arteries was analyzed by immunofluorescence staining. The endothelium was labelled by isolectin B4 (IB4, grey). Nuclei were stained with DAPI. (b) Number of p-AMPK+IB4+ endothelial cells per high-power field (HPF). (c) Percentage of endothelial coverage of the vascular lumen. Data are shown as mean ± SD, from three independent experiments. * P < 0.05. The statistical significance was assessed by Kruskal–Wallis test.CC BY · PubMed Central
Figure 8 Liraglutide attenuates diabetes-associated neointima formation and pathogenic EndMT via the AMPK pathway. (a) The proposed underlying mechanisms of the therapeutic effects of liraglutide on the attenuation of a diabetes-associated vascular injury. Upon diabetic conditions such as hyperglycaemia in combination with pro-inflammatory stimulation by IL-1β, endothelial cells undergo the pathogenic EndMT process with increased mesenchymal marker expression (vimentin and SM22α). Liraglutide, a GLP-1 agonist, activates downstream AMPK signaling via GLP-1R and attenuates diabetic insult-induced EndMT in endothelial cells. (b) In vivo, endothelium-derived smooth muscle-like cells contribute to the progression of neointima formation after a wire-induced carotid artery injury. Reduced neointima formation in diabetic mice upon liraglutide treatment may be partially attributed to the reduced EndMT process.
Figure 8 Liraglutide attenuates diabetes-associated neointima formation and pathogenic EndMT via the AMPK pathway. (a) The proposed underlying mechanisms of the therapeutic effects of liraglutide on the attenuation of a diabetes-associated vascular injury. Upon diabetic conditions such as hyperglycaemia in combination with pro-inflammatory stimulation by IL-1β, endothelial cells undergo the pathogenic EndMT process with increased mesenchymal marker expression (vimentin and SM22α). Liraglutide, a GLP-1 agonist, activates downstream AMPK signaling via GLP-1R and attenuates diabetic insult-induced EndMT in endothelial cells. (b) In vivo, endothelium-derived smooth muscle-like cells contribute to the progression of neointima formation after a wire-induced carotid artery injury. Reduced neointima formation in diabetic mice upon liraglutide treatment may be partially attributed to the reduced EndMT process.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 60 references

Cited by

See all 39

Metadata

Authors
Tsai, T.-H., Lee, C.-H., Cheng, C.-I., Fang, Y.-N., Chung, S.-Y., Chen, S.-M., Lin, C.-J., Wu, C.-J., Hang, C.-L., & Chen, W.-Y.
Affiliations
  • Chang Gung University (TW)
  • Kaohsiung Chang Gung Memorial Hospital (TW)
Corresponding author
Chen, Wei-Yu
Venue
Cells
Publisher
MDPI AG
Published
2019-06-14
Volume
8
Issue
6
Pages
589
ISSN
2073-4409 (ISSN-L)
OpenAlex
W2950515961
Cited by
37
References
62
Citations by year
2026: 4 · 2025: 6 · 2024: 3 · 2023: 7 · 2022: 4 · 2021: 9 · 2020: 3 · 2019: 1
FWCI
3.45
Type
journal article
Language
en
Open access
Locations
  • Cells (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Chang Gung Medical Foundation (CMRPG8E1151, CMRPG8F0351, CMRPG8B0601, CMRPG8D0231-3, CMRPG8E0661-3, CMRPG8F1831, CMRPG8F1681, CMRPG8G1371, CMRPG8G1541)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
liraglutide, endothelial-to-mesenchymal transition, neointima formation, diabetic vascular complications, hyperglycemia, endothelial dysfunction, re-endothelialization, carotid artery, streptozotocin-induced diabetes, GLP-1 receptor agonists, ALK5 inhibition, SB431542, AMPK signaling, human umbilical vein endothelial cells
MeSH terms
Liraglutide, Snail Family Transcription Factors, Adenylate Kinase, Animals, Arteries, Diabetes Mellitus, Experimental, Endothelium, Glucose, Humans, Mesoderm, Mice, Inbred C57BL, Mice, Transgenic, RNA, Messenger, Streptozocin, Signal Transduction, Biomarkers, Smad2 Protein, Glucagon-Like Peptide 1, Interleukin-1beta, Neointima, Human Umbilical Vein Endothelial Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Liraglutide Inhibits Endothelial-to-Mesenchymal Transition and Attenuates Neointima Formation after Endovascular Injury in Streptozotocin-Induced Diabetic Mice. https://app.cochat.ai/papers/10.3390/cells8060589
The paper
Tsai, T.-H., Lee, C.-H., Cheng, C.-I., Fang, Y.-N., Chung, S.-Y., Chen, S.-M., Lin, C.-J., Wu, C.-J., Hang, C.-L., & Chen, W.-Y. (2019). Liraglutide Inhibits Endothelial-to-Mesenchymal Transition and Attenuates Neointima Formation after Endovascular Injury in Streptozotocin-Induced Diabetic Mice. Cells. https://doi.org/10.3390/cells8060589

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.